In vivo "footprints" of the ginA regulatory region under activating conditions demonstrate that the three most upstream activator sequences bind the protein NRI in the cell. Together, protections at these sites span six of seven consecutive major grooves and lie on the same helix face. Ear54 
The glnALG operon ofEscherichia coli includes the genes for glutamine synthetase (glnA) and two nitrogen regulatory proteins, NRI (glnG) and NRII (glnL). Under conditions of nitrogen excess, both NRI and NRII exist at low levels, predominantly in their inactive forms (1) (2) (3) . When nitrogen becomes limiting, NRII is activated in response to a lower ratio of glutamine to a-ketoglutarate such that it can phosphorylate NRI (3) (4) (5) . When phosphorylated, NRI acts as a transcriptional activator using sequences in the promoter regions of a series of nitrogen (Ntr)-regulated operons (1, 3) .
In addition to NRI, all Ntr promoters also require &r' for their expression and thus share a consensus DNA sequence which differs from that of the major E. coli a7-promoters (6) (7) (8) .
Sequence analysis of the glnA promoter region revealed five potential NRI binding sites (1, 7, 9, 10) . All five lie upstream from the strong &4-dependent promoter glnAp2. The most upstream sites, NRI-1 and NRI-2, overlap a weak oJ7 promoter, ginApl (1, 10) . Low nitrogen availability results in high levels of expression from ginAp2 and repression (by NRI) at glnApl. DNase I protection experiments in vitro show that the strong NRI sites 1 and 2 have approximately equal affinity for NRI and exhibit no cooperativity in binding this protein (11) . Site 3 requires 4-to 5-fold higher concentrations of NRI to fill but in turn has a much greater affinity for NRI than do sites 4 and 5 (11) . In vivo expression assays and in vitro transcription experiments from a plasmid containing ginA and its promoter region demonstrate that sites 1 and 2 are critical for activation at low NRI concentrations (1, 11) .
The mechanism by which NRI activates transcription must involve several features that appear to be quite unusual, at least in prokaryotes. First, the two NR1 sites can exert their effects when placed 1400 base pairs (bp) further upstream or =2000 bp downstream from the glnAp2 transcriptional start site (1) . Second, at high NRI concentrations expression can occur in the absence of any NRI binding sites (1, 11) . Third, in vitro transcription assays suggest that NRI activates transcription by taking E&JS4 from a closed to an open complex (11) , although the possibility that it instead affects a step subsequent to open complex formation-for instance, promoter escape-cannot be ruled out. In this paper, we use in vivo "footprinting" to probe the mechanism of activation at this promoter in the cell.
MATERIALS AND METHODS
Strains, Media, and Materials. YMC10 (thi, endA, hsr, AlacU169, hutCk), YMC12 (YMC10, glnGJO::TnS), YMC22 (YMC10, rpoN208::TnlO), and TH16 (YMC10, glnA2l::TnS) (1, 10) were the kind gifts of B. Magasanik (Massachusetts Institute of Technology). Plasmids pLR1, pLR14, pLR12 (1) , and pLR88 [reconstructed by L. Reitzer from pLR8 (1)] were the kind gifts of L. Reitzer (University of Texas). Ggln, GNgln, and LBgln media were prepared as described (10, 12) . Klenow fragment was purchased commercially from Bethesda Research Laboratories. Rifampicin was purchased commercially from Sigma. Two primers, glnU (5'-CAGTCCCT-TTGTGATCGC-3') and glnD (5'-GGTCATGGTCGT-CGTGG-3'), hybridizing at -202 and +54 (5' position), respectively, were synthesized at the UCLA synthesizer facility.
In Vivo Footprinting. Cells bearing plasmid DNA to be footprinted were diluted 1:100 from an overnight culture into the same medium as the overnight culture (Ggln, GNgln, or LBgln) and grown to midlogarithmic phase (0.5-0.7 OD60). In the cases in which rifampicin was used, 40 .ul of rifampicin (50 mg/ml) in methanol was added to 10 ml ofcells for 5.0 min before treatment with dimethyl sulfate (DMS) or potassium permanganate. In vivo footprinting with DMS was as described (13) (14) (15) using the G or, in some cases, A>G cleavage reaction of Maxam and Gilbert (17) . When potassium permanganate was used as the DNA modifying reagent, 270 ,ul of 0.37 M KMnO4 was added to the cells for exactly 2 min at 37°C with shaking. At this time, the sample was poured directly into a chilled tube and the plasmid DNA was isolated as described (15, 16) . After phenol extraction and DNA precipitation, the samples treated with permanganate (14, 18) were dried and resuspended in 160-180 ,ul of TE buffer (10 mM Tris/1 mM EDTA, pH 8.0) at 50°C-55°C. Once dissolved, they were spun through a 1-ml G50-80 Sephadex column equilibrated in distilled water and brought to 160 ,l with distilled water for primer-extension analysis. Each sample (35 ,l) was analyzed by primer-extension analysis Abbreviation: DMS, dimethyl sulfate.
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(19) using alkaline denaturation as described (14, 15) . Hybridization to the glnU and glnD primers was carried out at 450C and 50'C, respectively. RESULTS Binding Pattern and Arrangement ofNRI Dimers in Vivo. To study NRI-and Eo 54-dependent binding in the cell, plasmid DNA containing ginA and its upstream sequences (pLR1) was footprinted in vivo by primer-extension analysis (13) (14) (15) 19) in three different strain backgrounds [YMC10 ("wt"), YMC12 (no NRI), and YMC22 (no &54) (1, 10)] and in both activating (Ggln, nitrogen deprivation) and nonactivating (GNgln, nitrogen excess) media (10) .
Initially, DMS was chosen as the DNA modifying reagent to probe specific contacts between the ginA promoter region and its regulatory proteins in vivo. Fig. 1 shows the autoradiograph from such experiments in which both downstream (Fig. 1A) and upstream (Fig. 1B) was also found in vitro (11) . There is some possibility that the regulation we observed with multicopy plasmids might be different from that which exists on the chromosome. For further comparison, we obtained preliminary low-resolution footprints of the chromosomal ginA regulatory sequences using DMS (data not shown). The results agree qualitatively with those from the plasmid studies in all respects. Quantitatively, the only differences included high occupancy of site 3 under activating conditions and a low partial occupancy of sites 1 and 2 when the cells were grown under nitrogen excess conditions where transcription occurs primarily from the weaker glnApi promoter (LBgln; ref. 10) .
In addition to revealing quantitative information about NR1 binding in vivo, the autoradiographs shown in Fig. 1 reveal details about the specific interaction of NRI with its binding sites. These are illustrated graphically on the helix map (20) shown in Fig. 2A , which includes the protection observed at site 3 along the chromosome. The map assumes 10.4 bp per turn and includes data from both G (Fig. 1) there is no such separation between sites 2 and 3, raising the possibility of cooperativity between these latter two sites.
Outside ofthe areas protected by NRI, and primarily within the minor grooves, lie sites that exhibit hyperreactivity to DMS attack (^). The pattern of attack may reflect both a modest bending of the DNA induced by the bound protein (see ref. 13 ) and a general distortion of the DNA between two bound NRI half sites.
Ea54 Occupancy of glnAp2 in Vivo. Fig. 1 also shows the DMS pattern at the downstream glnAp2 promoter region along both strands in the various strains and growth conditions. In some cases rifampicin, which traps RNA polymerase in an open complex, was added to the cells directly before DMS treatment (odd numbered lanes, excluding 11A). These samples are discussed below as the present analysis concentrates on footprints of the promoter region in its steady state (no rifampicin present; even-numbered lanes and 11A). Fig. 1 A and B . The DNA sequence (1, 9, 10) is also shown in alignment with each helix map. The continuity of the helix map was maintained between A and B. The helix maps indicate changes in the "wild-type" strain under activating conditions with respect to the in vitro naked DNA pattern (or to patterns in the YMC12 and YMC22 backgrounds). Protections at NRI site 3 observed along chromosomal DNA are included on this map. A and G residues are shown in the minor and major grooves, respectively, and include residues protected (o) and enhanced (^) in vivo. Bands made hyperreactive by rifampicin treatment are shown on the helix map (A). The sequence map also includes residues protected (0) and enhanced (Y) for reference. The protections remained the same when rifampicin was added to the cells with the exception of the band at -13, which then appeared unprotected. The separate areas of protection are outlined by the shaded regions. Two T residues (-142 on the bottom strand and -26 on the top strand) exhibited unexpected reactivity toward DMS attack and G cleavage both in vitro and in vivo by primer-extension analysis. Because the chemical site of methylation at these two T residues is unknown, the protections at -142 and -26 (dependent on NRI and Ea54, respectively) are not depicted on this helix map.
Proc. Natl. Acad. Sci. USA 85 (1988) those in which o-54 was missing from the background strain.
In all the other non-rifampicin-treated lanes (4A, 8A, 10A, and 11A), the bands from -24 to -26 weaken in intensity with respect to the relatively constant band at -19 and exhibit almost equal intensity compared with the bands from -29 to -31. A similar observation occurs along the bottom strand (Fig. 2B , compare the intensities of bands at -12 and -14 with that at -6).
These data demonstrate that protection of the downstream promoter region depends on 54 but not on NR,'s presence or nitrogen availability. Since 54 requires core RNA polymerase to bind this region in vitro, the observed changes are likely due to bound Ea54. Under nonactivating conditions, however, the bound enzyme must be inactive. This agrees well with conclusions from previous genetic (21) and in vitro (11, 22) experiments. The helix map of Fig. 2B illustrates the band changes at the glnAp2 promoter due to Eo'. Like the NRI-dependent interactions ( Fig. 2A) , all of the Ecr54 protections lie on one helix face. Also like NRI, the protections span two major grooves of the helix face; these contain the important -12 and -24 consensus elements for E. coli Ntr promoters (6) (7) (8) .
Interestingly, the -24 region shows a similar protection pattern to that seen at the right halfof each upstream NRI site with an additional protected G at -23 on the bottom strand. Again assuming 10.4 bp per turn, the helix maps also demonstrate that Eor54 and NRI bind predominantly to different faces of the helix (note that the correct spacing was maintained between the helix maps of Fig. 2 A and B) . Probing ginA DNA Opening in Vivo. In vitro transcription experiments suggest that NRI activates transcription from glnAp2 by helping prebound Ea,54 form an open complex (11) . DNA opening could not be followed directly in those experiments. However, we find that open complexes can be probed directly by using potassium permanganate, which reacts primarily with structurally distorted T and C residues in vitro (14) . Specifically, T and C residues from -10 to +3 at the lac promoter become very hyperreactive to permanganate when the lac operon is induced in vivo or when lac open We therefore probed open DNA in vivo at the ginA regulatory region with potassium permanganate. The results for the various background strains and media are shown in Fig. 3 . Lane 1 shows the pattern of bands obtained when the plasmid pLR1 is modified with permanganate in vitro. Most of these bands correspond to modifications at T and C residues. When this same plasmid DNA is treated with permanganate in vivo in a wild-type background and activating medium, the bands from -3 to +1 with respect to the start ofglnAp2 transcription become extremely hyperreactive (lane 3). The hyperreactivity of these bands depends on pretreatment with rifampicin (compare lanes 2 and 3) . This region therefore represents those pyrimidines on the top strand melted in an open complex between Eo 54 and the promoter DNA. However, the hyperreactivity does not appear in the presence of rifampicin when either NRI or a'J4 is absent from the background strain (see lanes 4 and 5) or under conditions of nitrogen excess (lanes 6-9). Similar results were obtained on the chromosome (data not shown). Open complex formation in vivo is therefore dependent on Eo&4, NRI, and nitrogen deficiency. This means that o-54-dependent footprints observed with DMS in vivo (Fig. 1) Various NRI site deletion plasmids, whose in vivo expression levels are known (1), were also modified with permanganate in vivo in the presence and absence of rifampicin under activating conditions (Fig. 3, lanes 10-15) . Again, the strong hyperreactivity of the bands from -3 to +1 for the various plasmids is absolutely dependent on rifampicin. However, the intensity of these bands depends on which NRI sites are In vivo modification of the wt (pLR1) and NRI deletion plasmids by using potassium permanganate. Lanes: 1, in vitro permanganate control pattern along pLR1; 2-9, pLR1 in vivo; 10 and 11, pLR14 (site 1 and half of site 2 deleted) in vivo; 12 and 13, pLR12 (sites 1-3 deleted) in vivo; 14 and 15, pLR88 (sites 1-4 deleted) in vivo; 16, in vitro DMS pattern along pLR1. The growth conditions and strain backgrounds are described at the top of the autoradiograph (see legend to Fig. 1 for key) .
Biochemistry: Sasse-Dwight and Gralla 8938 Biochemistry: Sasse-Dwight and Gralla signal decreases as NRI sites are deleted sequentially from the upstream direction (compare lanes 11, 13, and 15). Comparison of the intensities of the open complex signals for each deletion plasmid with the glutamine synthetase expression levels (1) for these same plasmids reveals that the loss of signal parallels the loss of expression. Thus, the upstream sites determine the probability of DNA opening, which in turn is roughly proportional to the level of expression.
In agreement with the permanganate results, when cells treated with rifampicin were footprinted with DMS rather than permanganate, strongly hyperreactive residues appeared downstream ofthe -12 protections only in a wild-type background and activating medium (Fig. 1, lanes 9A and 4B ; illustrated in Fig. 2 ). This hyperreactivity likely represents DNA opening (13 (18) , the symmetry of the protection patterns shown in Fig. 2A predicts that the two monomers bound at each site would possess domains pointing in opposite directions. In combination with the existence of three bound activator sites, this makes the fact that Eo54 and NRI protections lie on very different helix faces much less relevant; Eo54 could conceivably occupy almost any face ofthe helix and still lie on the same helix face as a single activator domain. Thus, multisite activation systems could have greater flexibility in both physical and evolutionary terms.
